|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 209 of 212 found articles
| Title: |
155TiP Phase II study of tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTE®) immuno-oncology therapy targeting DLL3, in third-line or later small cell lung cancer (SCLC) |
| Author: |
Ramalingam, S.S. Ahn, M-J. Akamatsu, H. Blackhall, F. Borghaei, H. Hummel, H-D. Johnson, M. Reck, M. Zhang, Y. Jandial, D. Cheng, S. Paz-Ares, L. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S2 pages S103-S104 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 209 of 212 found articles
| << previous | next >> |